<DOC>
	<DOCNO>NCT03034148</DOCNO>
	<brief_summary>In human purified platelet , thrombin , platelet agonist , lead transient activation protein kinase activate AMP ( AMPK ) phosphorylation `` bona fide '' substrate , ACC Ser79 . ACC phosphorylation ( P-ACC ) interest marker thrombin action platelet . Indeed platelet coagulation interplay , though undoubtedly present atherosclerosis atherothrombosis , remain difficult ass . Our group show atherosclerotic mouse ( SRBI/Apolipoprotein E knock-out ) high platelet P-ACC compare correspond control mouse ( C57BL6 ) . In agreement data , preliminary result show increased platelet P-ACC small cohort patient admit coronary angiogram , demonstrate coronary artery disease ( CAD ) . In light preliminary result , seek analyze platelet P-ACC large prospective clinical trial ( ACCTHEROMA ) patient admit coronary angiogram . The aim study compare platelet P-ACC platelets patient CAD particularly unstable CAD patient non-CAD patient . This study could potentially identify patient high risk future ischemic cardiovascular event , high level thrombin generation .</brief_summary>
	<brief_title>Platelet Acetyl Coenzyme A Carboxylase Phosphorylation Coronary Artery Disease</brief_title>
	<detailed_description>Consecutive patient plan coronary angiogram Cliniques Universitaires Saint Luc , Brussels , whatever indication , include March 2015 February 2016 . Informed consent obtain angiogram . A . Blood Sampling Routine veinous blood sample do fasting condition cardiology ward angiogram ( standard care patient undergo coronary angiogram ) . In order avoid additional puncture blood sample limit platelet activation , blood sample withdraw sheath insertion Cath lab drug administration . The following measurement do : - Routine coagulation test include international rationalize ratio , activate cephaline time , thrombin time , prothrombin time , Fibrinogen , DDimers . - Platelet reactivity test Multiple Electrode Aggregometer ( Multiplate Analysis ) - Platelet isolation lysates stocked frozen phospho-protein analysis immunoblotting electrochemiluminescence ( ECLIA ) - Aliquots poor platelet plasma stock frozen inflammation ( HsCRP ) , thrombin generation test ( thrombin-antithrombin complex , prothrombin fragment F1.2 , endogenous thrombin generation potential-ETP ) , platelet activation marker ( platelet factor 4 , soluble CD40ligand , soluble P-selectin ) circulate micro-RNA extraction . - Platelet isolation purification platelet specific micro-RNA extraction . B. Atherosclerosis evaluation All patient underwent coronary angiogram . Significant coronary artery lesion define luminal stenosis 50 % . Syntax score calculate patient . Global atherosclerotic plaque burden coronary extracoronary artery evaluate measure calcium score thoraco-abdominal scanner prospective ECG-gating randomly select subgroup patient . Coronary artery calcification ( CAC ) express Agatston score use calcium score software ( Philips Healthcare ) threshold 130 Hounsfield unit . The degree atherosclerotic burden coronary artery classify mild ( Agatston score &lt; 100 ) , moderate ( Agatston score 100-400 ) severe ( Agatston score &gt; 400 ) . Aortic calcification ( AoC score ) measure aortic arch iliac artery patient . C. Data collection Baseline characteristic patient collect medical database Cliniques Universitaires Saint Luc . All coronary angiogram review 2 different investigator syntax score calculated online syntax score calculator . CAC Agatston AoC score also assess 2 different investigator . D.Patients Classification platelet P-ACC analysis Platelet ACC phosphorylation ( P-ACC ) analysis do immunoblotting specific antibody probe phosphorylated ( Ser 79 ) ACC . Purified wash platelet stimulate 0.5 units/ml thrombin use positive internal control . Patients first classify non-CAD CAD group base result coronary angiogram CAC Agatston score : Non-CAD ( absence lesion angiogram and/or CAC Agatston score &lt; 100 ) CAD ( presence least 1 lesion angiogram and/or CAC Agatston score &gt; 100 ) . In second analysis , base clinical presentation , CAD group divide Stable CAD Unstable CAD [ acute coronary syndrome ( ACS ) ] . Platelet P-ACC compare subgroup . This detailed classification outline high-risk patient ongoing acute coronary syndrome . E. Sample size statistical analysis . Based preliminary data , determine enrolment 102 patient would provide power 80 % significance level 5 % detect difference 0.15 ( A.U . ) phosphorylation ACC atherosclerotic patient , compare non CAD patient . Continuous variable express mean +/- one standard deviation , categoric variable count percentage . Patients separate four group depend level P-ACC ( quartile ) . Clinical presentation , thrombin generation marker calcium score compare group , base ANOVA analysis . Variables submit logistic regression test order identify independent predictor high ACC phosphorylation state . The role high platelet P-ACC assess risk patient study . F.Follow-up A follow-up period 3 year plan . Events record follow-up period obtain medical database phone call do case miss data .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Coronary Thrombosis</mesh_term>
	<criteria>Signed informed consent Planned angiography within next 3 day , whatever indication . Not able sign inform consent Patients anticoagulation therapy ( oral parenteral ) include heparin , fondaparinux , vitamin K antagonist , novel oral anticoagulant , reason . Active neoplasia Active inflammatory disease Patients life expectancy low 3 year Haemophilia coagulopathy Abnormal platelet count Heart transplant patient Active hepatitis B C HIV patient Any contraindication coronary angiography .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Atherothrombosis</keyword>
	<keyword>Thrombin generation</keyword>
	<keyword>Platelet Acetyl Coenzyme A carboxylase phosphorylation</keyword>
</DOC>